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Summary
Background Fever with reduced consciousness is an important cause of hospital admission of children in sub-Saharan 
Africa, with high mortality. Cerebral malaria, diagnosed when acute Plasmodium falciparum infection and coma are 
recorded with no other apparent reason, is one important cause. We investigated whether viruses could also be an 
important cause of CNS infection in such patients, and examined the relative contribution of viral pathogens and 
malaria parasitaemia.
Methods We did a prospective cohort study in Blantyre, Malawi. From March 1, 2002, to Aug 31, 2004, we enrolled 
children aged between 2 months and 15 years who were admitted to hospital with suspected non-bacterial CNS 
infections. Children with a cerebrospinal ﬂ uid (CSF) white cell count of less than 1000 cells per μL and negative 
bacterial microscopy and culture were deemed to have suspected viral CNS infection. Blood was examined for asexual 
forms of P falciparum. PCR was done on CSF or on post-mortem brain biopsy specimens to detect 15 viruses known 
to cause CNS infection.
Findings Full outcome data were available for 513 children with suspected viral CNS infection, of whom 94 (18%) 
died. 163 children (32%) had P falciparum parasitaemia, of whom 34 (21%) died. At least one virus was detected in the 
CNS in 133 children (26%), of whom 43 (33%) died. 12 diﬀ erent viruses were detected; adenovirus was the most 
common, aﬀ ecting 42 children; mumps, human herpes virus 6, rabies, cytomegalovirus, herpes simplex virus 1, and 
enterovirus were also important. 45 (9%) of the 513 children had both parasitaemia and viral infection, including 
27 (35%) of 78 diagnosed clinically with cerebral malaria. Children with dual infection were more likely to have 
seizures than were those with parasitaemia alone, viral infection only, or neither (p<0·0001). 17 (38%) of the 
45 children with dual infection died, compared with 26 (30%) of 88 with viral infection only, 17 (14%) of 118 with 
parasitaemia only, and 34 (13%) of 262 with neither (p<0·0001). Logistic regression showed children with a viral CNS 
infection had a signiﬁ cantly higher mortality than did those who did not have a viral CNS infection (p=0·001).
Interpretation Viral CNS infections are an important cause of hospital admission and death in children in Malawi, 
including in children whose coma might be attributed solely to cerebral malaria. Interaction between viral infection 
and parasitaemia could increase disease severity.
Funding Wellcome Trust, US National Institutes of Health, and UK Medical Research Council.
Introduction
Febrile illness with reduced consciousness is one of the 
most important reasons for acute hospital admission of 
children in sub-Saharan Africa. One of the most 
common causes is cerebral malaria, which is due to 
sequestration of parasitised erythrocytes in the cerebral 
micro vasculature. Children are clinically diagnosed with 
this disorder if asexual forms of Plasmodium falciparum 
parasites are seen on a peripheral blood ﬁ lm, and if they 
are in an unrousable coma not attributable to any other 
cause.1 However, asymptomatic parasitaemia is 
common, occurring in up to 70% of children in sub-
Saharan Africa.2 Therefore, other possible causes of 
coma—eg, seizures, metabolic derangements, and other 
in fections—must be excluded before coma can be 
attributed to parasites alone. Previous studies have been 
focused on superimposed bacterial infections, par-
ticularly bacterial meningitis.3 Fundoscopic examination 
has helped to distinguish children who have retinal 
changes consistent with autopsy-proven cerebral 
malaria, from those who do not.4
Little attention has been paid to the possible role of viral 
CNS infections in comatose children in sub-Saharan 
Africa.5 We investigated whether viruses could be an 
important cause of CNS infection, are sometimes the 
cause of retinopathy-negative cerebral malaria, and could 
interact with malaria parasites to increase disease severity.
Methods
Study design and participants
We did a prospective cohort study in the paediatric unit 
of the Queen Elizabeth Hospital in Blantyre, Malawi—an 
area where P falciparum malaria is endemic. From 
March 1, 2002, to Aug 31, 2004, we enrolled children aged 
between 2 months and 15 years who had a suspected 
CNS infection. CNS infections were suspected in 
children with a fever or history of fever, who also met at 
least one of eight additional criteria: reduced level of 
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consciousness (Blantyre coma score6 [BCS] ≤4 for 
children aged 10 years or younger; or Glasgow coma 
score [GCS] ≤14 for children older than 10 years); neck 
stiﬀ ness; photophobia; Kernig’s sign; tense fontanelle; 
focal neurological signs; irritability (an inconsolable high 
pitched cry in a listless child); or convulsions other than 
simple febrile convulsions.7 We did not include children 
with simple febrile convulsion because most recover 
rapidly and this illness is less of a public health burden 
than are CNS infections.
The protocol was approved by the College of Medicine 
Research and Ethics Committee, Malawi, and the Ethics 
Committee of the Liverpool School of Tropical Medicine, 
UK. The study was explained to accompanying relatives 
of participating children, who provided written informed 
consent.
Procedures
On admission to hospital, children with a suspected CNS 
infection underwent a lumbar puncture. Cerebrospinal 
ﬂ uid (CSF) was taken for biochemical and bacteriological 
analysis, as described previously,8 and subsequent 
virological investigations. We excluded children from 
further study if they had bacterial meningitis proven by 
Gram stain or bacterial culture, or suspected on the basis 
of a CSF white cell count of at least 1000 cells per μL or a 
positive blood culture. We did not include children with 
suspected bacterial meningitis because they have already 
been much studied in our setting,9 and the number of 
additional cases of viral CNS infection was likely to be low.
Children with a CSF white cell count of less than 
1000 cells per μL and negative bacterial microscopy and 
culture were deemed to have suspected viral CNS 
infection. A member of the study team obtained a 
detailed history and did a detailed systemic and 
neurological examination on admission to hospital and 
at least twice daily until discharge or death. Details were 
recorded on a standard form. We deﬁ ned deep coma as a 
BCS of 2 or less or a GCS of 8 or less, depending on the 
age of the child.6,10,11 Routine cerebral imaging and 
electroencephalography were not available. Fundoscopic 
examination to look for retinal changes consistent with 
cerebral malaria (patchy retinal whitening, vessel colour 
changes, and white-centred haemorrhages) was possible 
in a subset of patients with deep coma with or without 
parasitaemia who were being investigated as part of 
another study of cerebral malaria.4 Children with 
parasitaemia were treated with oral sulfadoxine–
pyrimethamine or parenteral quinine if they had features 
of severe malaria. No antiviral drugs were available.
Blood was obtained on admission for haematocrit 
measurement, blood cultures, examination for asexual 
forms of P falciparum on thick blood ﬁ lm (with a 
simpliﬁ ed WHO method12), and HIV testing after 
counselling at the discretion of the treating clinician 
(with Uni-Gold [Trinity Biotech, Bray, Ireland] and 
Determine [Abbott Laboratories, Green Oaks, IL, USA])·
All CSF specimens were stored at –80°C before 
processing. With previously described methods, we 
extracted DNA and did PCR to detect adenovirus,13 
cytomegalovirus,14 Epstein-Barr virus,15 herpes simplex 
virus 1 and 2,16 human herpes virus 6 and 7,14 JC/BK 
virus,17 parvovirus B19,18 and varicella zoster virus. We 
identiﬁ ed adenovirus subgroups with restriction 
endonuclease analysis. We extracted RNA from CSF 
with the QIAamp Viral RNA Mini Kit (QIAGEN, 
Crawley, UK) and did PCR for mumps virus, 
enteroviruses, and parechoviruses.19 For measles virus, 
we designed primer probes for the haemagglutinin gene 
region with ABI Primer Express (Applied Biosystems, 
UK). We did diagnostic investigations for rabies on brain 
biopsy specimens from children who died, as described 
previously.20
Statistical analysis
We compared clinical features of the patients who died 
and those who survived with Fischer’s exact and Kruskal-
Wallis tests, as appropriate. We assessed factors 
associated with mortality with logistic regression. Several 
variables were of interest, such as sex, age, vomiting, 
hepatomegaly, splenomegaly, and HIV status. We did 
both univariate and multivariate logistic regression. 
We report odds ratios with 95% CIs. We used the 5% 
signiﬁ cance level. All analyses were done in SPSS 
(version 12.0) and Amos (version 6.0).
Role of the funding source
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
1230 children were admitted to hospital with suspected 
CNS infections, of whom 516 were deemed to have 
suspected viral CNS infection (ﬁ gure). Three were 
Figure: Trial proﬁ le
1230 children with suspected CNS infection
714 excluded
480 had bacterial meningitis
234 had simple febrile convulsions
516 with suspected viral CNS infection
3 excluded
3 missing data
513 included in analyses
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excluded because of incomplete data, leaving 513 chidren. 
Median age was 2 years (table 1).
A substantial proportion of children had a history of 
seizures (table 1). 144 (28%) presented in deep coma. 
More than a third had CSF pleocytosis (median white cell 
count 18 cells per mm³, IQR 10–60; table 1).
94 children (18%) died. 363 (71%) made apparent full 
recoveries, and 56 (11%) had neurological sequelae at 
discharge (including motor and cognitive deﬁ cits). 
Univariate analysis showed that a history of 
unconsciousness, deep coma on admission, abnormal 
ﬁ ndings on chest examination, and high CSF opening 
pressure were associated with a fatal outcome (table 1). 
However, on multivariate analysis, only deep coma and 
high CSF opening pressure were independently 
predictive of death (table 1). HIV status was established 
for 140 children (27%), of whom 49 (35%) were HIV 
positive. In both multivariate and univariate analysis, a 
negative HIV test was associated with survival, but a 
positive test or no test was associated with death (table 1).
163 children (32%) had P falciparum parasitaemia, of 
whom 34 (21%) died compared with 60 (17%) of 
348 without parasitaemia (p=0·12). We recorded no 
association between the density of parasitaemia and 
outcome (data not shown). Children with parasitaemia 
were signiﬁ cantly older (median age 31 months, 
IQR 2–156) than were those without parasitaemia 
(18 months, 1–168; p<0·0001), and were more likely to 
All (n=513) Survived (n=419) Died (n=94) Odds ratio (95% CI)*
Unadjusted Adjusted
Characteristics
Male sex 281 (55%) 225 (54%) 56 (60%) 1·3 (0·8–2·0) 1·2 (0·6–2·0)
Age (months) 24 (7–51) 24 (7–48) 24 (9–72) ·· ··
Seizures 204 (40%) 161 (38%) 43 (46%) 1·3 (0·9–2·1) 2·3 (0·7–8·1)
Unconsciousness 121 (24%) 91 (22%) 30 (32%) 1·7 (1·0–2·7)† 1·0 (0·4–2·3)
Fever ≥3 days 188 (37%) 153 (37 %) 35 (37%) ·· ··
Vomiting 70 (14%) 57 (14 %) 13 (14%) 1·3 (0·6–2·8) ··
Diarrhoea 40 (8%) 32 (8%) 8 (8%) 1·4 (0·6–3·3) ··
Runny nose 41 (8%) 35 (8 %) 6 (6%) 1·0 (0·4–2·7) ··
Headache 36 (7%) 33 (8%) 3 (3%) 0·9 (0·6–1·4) ··
Examination
Temperature ≥39°C 48 (9%) 39 (9%) 9 (10%) 1·0 (0·5–2·2) 0·4 (0·1–1·3)
Deep coma 144 (28%) 93 (22%) 51 (54%) 4·2 (2·6–6·6)† 6·7 (3·3–13·8)‡
Bulging fontanelle 12 (2%) 7 (2%) 5 (5%) 3·3 (1·0–10·6) 1·5 (0·4–6·8)
Neck stiﬀ ness 39 (8%) 31 (7%) 8 (9%) 1·2 (0·5–2·6) 1·5 (0·5–4·7)
Abnormal chest 26 (5%) 18 (4%) 8 (9%) 2·1 (1·1–3·8)† 1·6 (0·7–3·8)
Hepatomegaly 55 (11%) 43 (10 %) 12 (13%) 1·6 (0·7–3·5) ··
Splenomegaly 54 (11%) 47 (11%) 7 (7%) 0·7 (0·3–1·6) ··
Hepatosplenomegaly 36 (7%) 31 (7%) 5 (5%) 0·8 (0·3–2·1) ··
Flexor posturing 9 (2%) 5 (1%) 4 (4 %) 3·7 (1·0–13·9) 6·7 (0·8–59·3)
Extensor posturing 6 (1%) 5 (1 %) 1 (1%) 0·9 (0·1–7·7) 0·2 (0·0–4·0)
Opisthotonus 12 (2%) 9 (2%) 3 (3%) 1·5 (0·4–5·6) 0·8 (0·1–6·5)
Observed seizure 19 (4%) 13 (3%) 6 (6%) 2·0 (0·7–5·2) 1·4 (0·3–5·7)
Investigations
CSF opening pressure ≥230 cm 8 (2%) 3 (1%) 5 (5%) 7·8 (1·8–33·0)† 18·0 (2·7–121·6)‡
CSF white cell count >5 per μL 188 (37%) 152 (36%) 36 (38%) 1·4 (0·9–2·4) 1·6 (0·9–2·8)
HIV status
Positive 49 (10%) 32 (8%) 17 (18%) 6·6 (2·5–17·4)† 17·1 (4·3–67·3)‡
Negative 91 (18%) 84 (20%) 7 (7%) ·· ··
Not known 373 (73%) 303 (72 %) 70 (74%) 2·8 (1·2–6·3)† 8·6 (2·4–30·9)‡
Malaria parasitaemia and CNS virus 45 (9%) 28 (7%) 17 (18%) 4·0 (2·0–8·1) 1·9 (0·7–5·2)
Malaria parasitaemia and no CNS virus 118 (23%) 101 (24%) 17 (18%) 1·1 (0·6-2·1) 0·8 (0·4–1·8)
CNS virus but no malaria parasitaemia 88 (17%) 62 (15%) 26 (28%) 2·8 (1·6–5·0) 2·3 (1·1–4·9)
No malaria parasitaemia or CNS virus 260 (51%) 226 (54%) 34 (36%) 1 1
Data are n (%) or median (IQR), unless otherwise stated. CSF=cerebrospinal ﬂ uid. *Comparison of children who survived and died. †Signiﬁ cant on univariate analysis. ‡Signiﬁ cant 
on multivariate analysis.
Table 1: Clinical features at presentation and initial investigations by outcome 
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present in deep coma (78 [48%] vs 66 [19%]; p<0·0001). 
58 children with malaria parasitaemia (36%) had an HIV 
test, of whom 14 (24%) were HIV positive. Fundoscopy 
was done in 90 children. 44 children (49%) had 
parasitaemia, of whom 20 (45%) had evidence of malaria 
retinopathy. None of 46 patients without parasitaemia 
had retinopathy.
At least one virus was detected in the CNS in 
133 children (26%). The most commonly detected virus 
was adenovirus, followed by mumps virus, human 
herpes virus 6, and rabies virus (table 2). 43 children with 
a CNS virus (33%) died compared with 51 (13%) of 378 
with no CNS virus detected (p<0·0001; table 1). Seizures 
and deep coma were common in children with a CNS 
virus (table 2). The highest mortality was for rabies virus, 
followed by cytomegalovirus (table 2).
The median age of children with a viral CNS infection 
was 26 months (IQR 7–72) compared with 23 (8–48) for 
those with no virus (p=0·1843). Of the 41 children with a 
viral CNS infection who were tested for HIV, 12 (29%) 
were positive; of the 99 with no viral CNS infection who 
were tested for HIV, 37 (37%) were positive (p=0·0438).
Adenovirus 
(n=42)
Cytomegalovirus 
(n=12)
Enterovirus 
(n=8)
Herpes simplex 
virus 1 (n=8)
Human herpes 
virus 6 (n=16)
Mumps virus 
(n=29)
Rabies virus 
(n=14)
Other virus 
(n=14)*
No virus 
(n=380)
Characteristics
Male sex 22 (52%) 7 (58%) 6 (75%) 7 (88%) 12 (75%) 15 (52%) 11 (79%) 8 (57%) 193 (51%)
Age (months) 15 (6–48) 12 (3–15) 21 (9–26) 27 (16–51) 24 (9–42) 30 (7–78) 84 (72–132) 36 (13–72) 23 (8–48)
Seizures 19 (45%) 5 (42%) 3 (38%) 3 (38%) 9 (56%) 8 (28%) 6 (43%) 10 (71%) 141 (37%)
Unconsciousness 3 (7%) 4 (33%) 1 (13%) 3 (38%) 7 (44%) 8 (28%) 5 (36%) 6 (43%) 84 (22%)
Fever ≥3 days 16 (38%) 1 (8%) 3 (38%) 3 (38%) 6 (38%) 10 (34%) 0 6 (43%) 143 (38%)
Vomiting 3 (7%) 1 (8%) 1 (13%) 4 (50%) 5 (31%) 4 (14%) 0 1 (7%) 51 (13%)
Diarrhoea 4 (10%) 2 (17%) 1 (13%) 0 2 (13%) 1 (3%) 0 1 (7%) 29 (8%)
Runny nose 6 (14%) 2 (17%) 2 (25%) 1 (13%) 3 (19%) 1 (3%) 0 2 (14%) 24 (6%)
Headache 2 (5%) 0 1 (13%) 3 (38%) 2 (13%) 2 (7%) 0 0 26 (7%)
Examination
Temperature ≥39°C 3 (7%) 1 (8%) 0 0 1 (6%) 1 (3%) 2 (14%) 1 (7%) 39 (10%)
Deep coma 12 (29%) 6 (50%) 1 (13%) 3 (38%) 7 (44%) 9 (31%) 4 (29%) 5 (36%) 101 (27%)
Bulging fontanelle 1 (2%) 2 (17%) 0 1 (13%) 3 (19%) 0 0 0 5 (1%)
Neck stiﬀ ness 2 (5%) 4 (33%) 0 0 1 (6%) 1 (3%) 4 (29%) 1 (7%) 26 (7%)
Abnormal chest 6 (14%) 2 (17%) 1 (13%) 1 (13%) 2 (13%) 0 0 2 (14%) 12 (3%)
Hepatomegaly 4 (10%) 1 (8%) 2 (25%) 3 (38%) 3 (19%) 2 (7%) 0 1 (7%) 39 (10%)
Splenomegaly 3 (7%) 0 1 (13%) 3 (38%) 2 (13%) 3 (10%) 0 1 (7%) 41 (11%)
Hepatosplenomegaly 3 (7%) 0 1 (13%) 2 (25%) 2 (13%) 1 (3%) 0 1 (7%) 27 (7%)
Flexor posturing 0 1 (8%) 0 0 2 (13%) 2 (7%) 0 0 4 (1%)
Extensor posturing 0 0 0 0 1 (6%) 1 (3%) 0 0 4 (1%)
Opisthotonus 1 (2%) 1 (8%) 0 0 0 0 0 0 10 (3%)
Observed seizure 5 (12%) 0 0 0 2 (13%) 0 1 (7%) 1 (7%) 12 (3%)
Investigations
CSF opening pressure ≥230 cm 0 1 (8%) 0 0 1 (6%) 0 2 (14%) 0 4 (1%)
CSF white cell count >5 per μL 11 (26%) 1 (8%) 4 (50%) 2 (25%) 0 11 (38%) 2 (14%) 8 (57%) 149 (39%)
HIV status
Positive 0 2 (17%) 1 (13%) 0 2 (13%) 2 (7%) 0 2 (14%) 40 (11%)
Negative 11 (26%) 1 (8%) 1 (13%) 0 7 (44%) 7 (24%) 0 3 (21%) 61 (16%)
Not known 29 (69%) 6 (50%) 5 (63%) 0 6 (38%) 19 (66%) 14 (100%) 10 (71%) 284 (75%)
Malaria parasitaemia and CNS virus 11 (26%) 3 (25%) 0 2 (25%) 5 (31%) 7 (24%) 5 (36%) 8 (57%) ··
CNS virus but no malaria parasitaemia 26 (62%) 5 (42%) 5 (63%) 5 (63%) 7 (44%) 19 (66%) 9 (64%) 6 (43%) ··
Outcome
Sequelae 4 (10%) 2 (17%) 2 (25%) 0 2 (13%) 3 (10%) 0 2 (14%) 39 (10%)
Died 11 (26%) 10 (83%) 3 (38%) 1 (13%) 1 (6%) 5 (17%) 14 (100%) 3 (21%) 46 (12%)
Data are n (%) or median (IQR). 11 patients (not shown here) had dual virus infections; each patient had a diﬀ erent combination of viruses: adenovirus in ﬁ ve cases, human herpes virus in four, cytomegalovirus 
in four, enterovirus in three, mumps in three, herpes simplex virus in one, measles in one, and parvovirus in one. Genotyping indicated that seven of the adenoviruses detected were members of subgroup B, one 
was subgroup C. Median age of patients with dual infection was 18 months (IQR 15–26), and Blantyre coma score on admission 3 (2–5). Seven patients with dual infection had malaria parasitaemia, three were 
HIV positive (of ﬁ ve tested), and three had a CSF pleocytosis.·Six children (55%) with dual viral infections died. CSF=cerebrospinal ﬂ uid.*Epstein-Barr virus (ﬁ ve patients), parvovirus (ﬁ ve), human herpes virus 7 
(two), measles (one), JC/BK virus (one).
Table 2: Clinical features and initial investigations by virus 
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To further examine the relation between malaria 
parasitaemia, viral CNS infection, and outcome, we 
divided the patients into four groups depending on their 
malaria and viral infection status (table 3). 45 (9%) of the 
513 children had both a viral CNS infection and malaria 
parasitaemia. No speciﬁ c virus was associated with 
parasitaemia (table 2). In an unadjusted comparison, we 
examined diﬀ erences between the four groups in clinical 
presentation. The proportion of children with a history of 
seizures was highest for those with malaria and viral 
CNS infection, followed by those with malaria only, those 
with neither infection, and those with only viral infection 
(table 3). The four groups also diﬀ ered signiﬁ cantly in 
the proportion with a history of unconsciousness and 
presenting in deep coma, both characteristics being most 
common in children with dual infection (table 3). 
27 (35%) of 78 children who had malaria parasitaemia 
and deep coma (ie, fulﬁ lled the clinical deﬁ nition of 
cerebral malaria) also had a viral CNS infection (table 3).
The proportion of patients with ﬂ exor posturing and 
ﬂ accid paralysis diﬀ ered signiﬁ cantly between groups 
(table 3). Viruses were detected in the CSF of ﬁ ve (25%) 
of 20 children with parasitaemia and malaria retinopathy, 
two of whom died, compared with eight (33%) of 
24 children with parasitaemia who had normal 
fundoscopy, none of whom died.
Outcome diﬀ ered signiﬁ cantly between the four 
groups, with a fatal outcome most common in patients 
 Malaria parasitaemia No malaria parasitaemia p value*
CNS virus 
(n=45)
No CNS virus 
(n=118)
Unadjusted odds 
ratio (95% CI)
CNS virus 
(n=88)
No CNS virus 
(n=262)
Unadjusted odds 
ratio (95% CI)
Characteristics
Male sex 28 (62%) 60 (51%) 1·6 (0·7–3·4) 52 (59%) 141 (54%) 1·2 (0·7–2·1) 0·479
Age (months) 34 (9–72) 30 (15–50) 1·0 (1·0–1·0) 23 (6–78) 14 (6–48) 1·0 (1·0–1·0) 0·001
Seizures 32 (71%) 51 (43%) 3·2 (1·5–7·4) 30 (34%) 91 (35%) 0·97 (0·6–1·7) <0·0001
Generalised 27 (60%) 37 (31%) 3·2 (1·5–7·1) 25 (28%) 72 (27%) 1·0 (0·6–1·8) <0·0001
Focal 6 (13%) 8 (7%) 2·1 (0·6–7·4) 3 (3%) 15 (6%) 0·6 (0·1–3·0) 0·172
Previous history 8 (18%) 8 (7%) 2·6 (0·8–8·0) 6 (7%) 19 (7%) 1·1 (0·4–3·0) 0·139
Unconsciousness 23 (51%) 44 (37%) 2·1 (0·8–8·0) 13 (15%) 41 (16%) 1·4 (0·6–3·0) <0·0001
Fever ≥3 days 16 (36%) 48 (41%) 1·6 (0·6–3·8) 29 (33%) 95 (36%) 0·9 (0·5–1·8) 0·719
Vomiting 9 (20%) 20 (17%) 1·2(0·4–3·1) 8 (9%) 33 (13%) 0·7 (0·3–1·6) 0·208
Diarrhoea 2 (4%) 10 (8%) 0·5 (0·1–2·5) 8 (9%) 20 (8%) 1·2 (0·4–3·0) 0·841
Runny nose 6 (13%) 5 (4%) 3·5 (0·8–15·1) 8 (9%) 22 (8%) 1·1 (0·4–2·7) 0·209
Headache 2 (4%) 14 (12%) 0·3 (0·0–1·6) 8 (9%) 12 (5%) 1·1 (0·4–2·8) 0·054
Examination
Temperature ≥39°C 3 (7%) 19 (16%) 0·6 (0·4–1·0) 5 (6%) 21 (8%) 1·1 (0·8–1·6) 0·022
Deep coma 27 (60%) 51 (43%) 0·5 (0·3–1·0) 16 (18%) 50 (19%) 1·1 (0·8–2·0) <0·0001
Bulging fontanelle 1 (2%) 1 (1%) 2·0 (0·1–78·2) 5 (6%) 5 (2%) 3·1 (0·7–13·8) 0·142
Neck stiﬀ ness 1 (2%) 4 (3%) 0·5 (0·1–4·7) 6 (7%) 28 (11%) 0·6 (0·2–1·6) 0·044
Abnormal chest 3 (7%) 4 (3%) 2·0 (0·3–12·5) 9 (10%) 10 (4%) 2·9 (1·0–18·1) 0·091
Hepatomegaly 10 (22%) 26 (22%) 0·7 (0·3–2·0) 5 (6%) 14 (5%) 1·1 (0·4–3·5) <0·0001
Splenomegaly 10 (22%) 22 (19%) 1·0 (0·4–2·7) 3 (3%) 19 (7%) 0·4 (0·1–1·6) <0·0001
Flaccid paralysis 2 (4%) 11 (9%) 0·3 (0·1–1·5) 1 (1%) 7 (3%) 0·4 (0·0–3·3) <0·0001
Spastic paralysis 4 (9%) 5 (4%) 2·0 (0·5–8·3) 6 (7%) 9 (3%) 1·9 (0·5–6·8) 0·442
Flexor posturing 3 (7%) 5 (4%) 1·4 (0·3–6·3) 0 1 (<1%) ·· 0·002
Extensor posturing 1 (2%) 2 (2%) 1·1 (0·1–12·8) 0 3 (1%) ·· 0·550
Opisthotonus 0 4 (3%) ·· 1 (1%) 7 (3%) 0·4 (0·0–3·3) 0·661
Extensor plantar 7 (16%) 16 (14%) 1·1 (0·4–3·3) 8 (9%) 24 (9%) 1·4 (0·5–3·8) 0·372
Observed seizure 6 (13%) 6 (5%) 2·6 (0·7–9·2) 2 (2%) 7 (3%) 0·9 (0·2–4·8) 0·017
Investigations
CSF opening pressure ≥230 cm 2 (4%) 5 (4%) 1·2 (0·2–7·9) 0 1 (<1%) ·· 0·930
CSF white cell count >5 per μL 11 (24%) 48 (41%) 0·5 (0·3–1·0) 31 (35%) 98 (37%) 1·1 (0·6–1·8) 0·501
HIV positive 4 (9%) 10 (8%) 0·9 (0·2–3·2) 8 (9%) 27 (10%) 0·6 (0·2–1·7) 0·971
Outcome
Died 17 (38%) 17 (14%) 3·6 (1·6–8·0) 26 (30%) 34 (13%) 2·8 (1·6–5·0) <0·0001
Data are n (%) or median (IQR), unless otherwise stated. CSF=cerebrospinal ﬂ uid. *Unadjusted comparison across all four groups.
Table 3: Clinical features and initial investigation by malaria parasitaemia and viral CNS infection
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with parasitaemia and viral infection (table 3). Logistic 
regression analysis showed that children with a viral CNS 
infection had a signiﬁ cantly higher mortality than did 
those who did not have a viral CNS infection (p=0·001), 
but we recorded no signiﬁ cant diﬀ erence in mortality 
between those who were positive or negative for malaria 
parasitaemia, irrespective of virus status (p=0·705)·
Discussion
We have shown that viral CNS infections are an 
important cause of hospital admission and death in 
Malawian children (panel). A third of the children who 
met the case deﬁ nition for cerebral malaria had viral 
infections, including a quarter of the children who had 
the characteristic retinal changes thought to be diagnostic 
of cerebral malaria. Although fewer patients had viral 
infection than parasitaemia, more children with viral 
infection died, even when patients with rabies—which is 
uniformly fatal—were excluded.
The number of patients with viral CNS disease might 
have been even higher had we included children with 
suspected bacterial meningitis or simple febrile 
convulsions. However, in a study of 142 children with 
suspected bacterial meningitis,21 a virus was detected in 
the CSF of just one patient with more than 1000 white 
blood cells in the CSF.
A study of Kenyan children5 previously showed that ten 
of 96 children with encephalopathy were infected with 
herpes simplex virus, but only tests for this virus and 
enteroviruses were done. In our study, viruses were 
detected in the CNS of a quarter of 513 patients studied. 
Although this frequency is similar to that in studies from 
Europe, the Americas, and Asia,22–24 the range of infections 
was diﬀ erent. In developed countries, herpes simplex 
virus, varicella zoster virus, and enteroviruses are major 
causes of CNS infection; by contrast, we recorded that 
adenovirus was the most common virus, accounting for 
about a third of cases of viral CNS infection. Adenoviruses 
most often cause respiratory illness or conjunctivitis. In 
the past, when only serological tests were available, their 
role in causing neurological disease was unclear. With 
widespread use of CSF PCR, adenoviruses have been 
associated increasingly with a range of neurological 
syndromes, such as acute ﬂ accid paralysis, meningitis, 
and encephalitis, sometimes with immunohistochemical 
conﬁ rmation.25–27 In our study, about a quarter of patients 
with adenovirus infection died, which is similar to the 
frequency in previous reports.28
Clearly, further work is needed to explore the role of 
adenoviruses in CNS disease in this setting. Few large 
series examining CNS infections have been focused on 
adenoviruses and, as far as we are aware, we are the ﬁ rst 
to do so in sub-Saharan Africa. Whether speciﬁ c features 
make individuals in this region particularly susceptible 
to adenovirus CNS infection—eg, immunodeﬁ ciency 
due to HIV, poor nutritional state, malaria, or anaemia—
will need to be investigated. 
The high frequency of mumps encephalitis in our 
study was probably a result of poor routine vaccination; 
the virus’s importance in aseptic meningitis has been 
shown previously in South Africa.29 By contrast, only one 
child had measles encephalitis in our study, which is a 
result of successful vaccination. Human herpes virus 6 is 
being recognised increasingly as a cause of encephalitis 
in children in all settings,30 although false positives can 
occur because of chromosomal integration.31 CNS 
infection of the brain with cytomegalovirus is especially 
common in people who are HIV positive; in our study, 
more than 40% of children with cytomegalovirus 
infection were HIV positive, and many of them also had 
an additional virus detected in their CSF. Since our study 
was done, antiretroviral therapy for HIV has become 
increasingly available in Malawi. Although we recorded 
some diﬀ erences in the clinical features at presentation 
for the diﬀ erent viruses—eg, hydrophobia for patients 
with rabies and a high proportion of patients with human 
herpes virus 6 aﬀ ected by seizures—clinical features 
could, for the most part, not be used to distinguish 
between the diﬀ erent viral infections.
We focused on the CNS, but had we also examined 
blood, throat, and rectal swabs, we might have detected 
viruses in more patients than we report here. However, if 
we had examined such samples, we would then have had 
Panel: Research in context
Systematic review
We searched PubMed for studies of viral CNS infections in 
sub-Saharan Africa, with the terms “virus” and “CNS 
infection”, “meningitis”, or “encephalitis”. We included reports 
published in English between Jan 1, 1966, and Jan 1, 2013. We 
reﬁ ned the search to exclude reports describing polio 
eradication. Although malaria and bacteria have been widely 
studied as causes of CNS disease in sub-Saharan Africa, little 
work on viral pathogens has been done. Previous studies have 
shown that enteroviruses, herpes simplex virus, and mumps 
could be important.5
Interpretation
We tested children with suspected non-bacterial CNS 
infection for 15 diﬀ erent viruses and have shown that viral 
CNS infections are much more common than previously 
suspected. We recorded a range of pathogens that is diﬀ erent 
from that typically reported in developed nations. Viral 
pathogens were identiﬁ ed in a third of comatose children 
with malaria parasitaemia who might otherwise have been 
diagnosed as having cerebral malaria. Children with dual viral 
and parasitic infection had more severe disease than did 
others, suggesting an interaction between the two. 
Importantly, viral infections overall were associated with 
more fatal cases than was malaria parasitaemia. These results 
have important implications for malaria control and 
management of patients with suspected CNS infections in 
sub-Saharan Africa.
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to try to establish whether any identiﬁ ed peripheral 
infection was causal or not.32,33 Antibody testing of CSF 
with paired blood samples might also have been helpful, 
but CSF volumes were small, and so, as with previous 
studies, we opted for the strictest criteria to deﬁ ne CNS 
infections, concentrating on virus detection in the CNS 
itself.22 Many children were negative for both malaria 
parasites and viral pathogens. They tended to be younger 
than those who were positive for either, but had no other 
distinguishing features.
Without our detailed investigation, the altered 
consciousness of children who met the case deﬁ nition for 
cerebral malaria would have been attributed solely to 
malaria. Do such patients have a viral CNS infection and 
coincidental malaria parasitaemia? Asymptomatic 
parasitaemia certainly does occur, and coincidental 
P falciparum infection is recognised in patients with 
bacterial meningitis.3 Alternatively, could patients have a 
coincidental viral infection? Although detection of viruses 
outside the CNS, particularly from non-sterile sites such 
as the rectum, might be coincidental,32 virus detected 
within the CNS is usually deemed to be pathogenic, 
especially if it is associated with a recognised neurological 
syndrome. Exceptions are some of the herpes viruses: 
human herpes virus 6 is known to integrate within 
leucocytes in about 1% of the population, and thus might 
be coincidentally detected. Additionally, Epstein-Barr 
virus and cytomegalovirus lie latent within lymphocytes; 
their role in encephalitis and other CNS diseases is 
recognised increasingly in both immunocompetent and 
immuno compromised patients.34,35 Quantiﬁ cation of viral 
loads might have provided additional information in our 
study, but at the time was not routinely available for all 
viruses studied. However, Epstein-Barr virus is often 
detected in the CSF of patients with HIV and bacterial 
meningitis, and higher loads are associated with a worse 
outcome.36 In other studies, Epstein-Barr virus messenger 
RNA from the replication cycle has been detected in the 
CSF of patients with CNS infections,37 and production of 
high titres of intrathecal antibodies34 in such patients has 
been shown, all of which is consistent with Epstein-Barr 
virus replicating and causing disease, rather than simply 
lying latent in lymphocytes.
A post-mortem study38 showed that 23% of children in 
Malawi who fulﬁ lled the WHO deﬁ nition of cerebral 
malaria died of other causes. Retinopathy was the only 
clinical sign that could be used to distinguish between 
children with cerebral sequestration of parasitised 
erythrocytes and those without sequestration. In that 
study,38 the other causes included Reye’s syndrome, 
ruptured arteriovenous malformation, and hepatic 
necrosis, but detailed virological work-up was not done 
as in our study. We noted that viral CNS infection was 
equally common in children with parasitaemia with or 
without retinal changes of cerebral malaria, which 
suggests that some of our patients could have had viral 
CNS infection with coincidental parasitaemia, while 
others had viral CNS infection and cerebral malaria, as 
deﬁ ned by fundoscopy. Although the numbers were 
small, there was no diﬀ erence in mortality between 
children with and without malaria retinopathy. This 
ﬁ nding agrees with another study39 that showed similar 
outcomes for children meeting the clinical case deﬁ nition 
for cerebral malaria, whether or not they had retinopathy.
Diﬀ erent viruses have diﬀ erent clinicoepidemiological 
patterns and disease mechanisms. However, if they are 
grouped together, as is done for bacteria in bacteraemia 
studies, overall disease burden can be examined. We 
recorded that children with malaria parasitaemia and viral 
co-infection were more likely to present with seizures than 
were those with either infection alone or neither infection, 
raising the possibility that both pathogens contribute to 
the pathogenesis in patients with dual infections. How 
viruses and malaria parasites might interact is unknown. 
In studies of sepsis and malaria, the eﬀ ect of microvascular 
parasite sequestration on the integrity of the gut mucosa is 
thought to allow bacterial seeding into the blood stream 
and hence bacteraemia.40 A similar eﬀ ect, disrupting the 
endothelial cell junctional proteins of the blood–brain 
barrier,41 might damage the barrier and allow virus into the 
CNS; in which case, detection of virus in the CSF could be 
a result of this disruption, with the virus playing no part in 
pathogenesis. Additionally, viruses are known to trigger 
upregulation of vascular endothelial adhesion molecules, 
such as ICAM-1,42 which might lead to increased 
sequestration of parasitised erythrocytes, thus exacerbating 
malaria-related cerebral injury. The interactions between 
diﬀ erent pathogens and their aggregate eﬀ ect on an 
infected individual are incompletely understood and 
poorly investigated.43
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